Brought to you by 
Versicor merges with Biosearch Italia in $234mm stock swap
Aug 2002
Executive Summary
Anti-infectives specialist Versicor plans to acquire antibiotic developer Biosearch Italia in a stock-for-stock transaction totaling about Euro236mm ($234.3mm). Versicor will issue 1.77 shares of its own stock (worth $19.27) for each Biosearch outstanding share, a 38% premium over market average.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Stock
- Includes Contract
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Versicor merges with Biosearch Italia in $234mm stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice